Litcius/Paper detail

Sacubitril/valsartan attenuates myocardial ischemia/reperfusion injury via inhibition of the GSK3β/NF-κB pathway in cardiomyocytes

Fangping Xiao, Lei Wang, Meng Liu, Mingyue Chen, Hao He, Zhiqiang Jia, Lai Zhang, Yaqing Yang, Qianfan Hu, Mei Hong, Hanwen Zhang

2022Archives of Biochemistry and Biophysics14 citationsDOI

Topics & Concepts

ValsartanInflammationAngiotensin IIPharmacologyAngiotensin II receptor type 1MedicineApoptosisReperfusion injuryVentricular remodelingReceptorAngiotensin receptorSacubitrilProinflammatory cytokineIschemiaInternal medicineEndocrinologyChemistryHeart failureBiochemistryBlood pressureCardiac Ischemia and ReperfusionSignaling Pathways in DiseaseCardiac Fibrosis and Remodeling
Sacubitril/valsartan attenuates myocardial ischemia/reperfusion injury via inhibition of the GSK3β/NF-κB pathway in cardiomyocytes | Litcius